BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16502797)

  • 21. [Is it time for revision of the section on obsessive-compulsive disorder in the Guideline on Anxiety Disorders?].
    van Ingen Schenau WJ; Wisman PW
    Tijdschr Psychiatr; 2007; 49(5):315-25. PubMed ID: 17492582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the understanding and treatment of anxiety disorders.
    Shearer SL
    Prim Care; 2007 Sep; 34(3):475-504, v-vi. PubMed ID: 17868756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dependence on benzodiazepine and treatment of withdrawal syndrome].
    Sep-Kowalikowa B; Czucha M
    Psychiatr Pol; 2002; 36(6 Suppl):347-57. PubMed ID: 12647459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current use of benzodiazepines in anxiety disorders.
    Cloos JM; Ferreira V
    Curr Opin Psychiatry; 2009 Jan; 22(1):90-5. PubMed ID: 19122540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Let's talk facts about anxiety disorders.
    American Psychiatric Association
    J Okla State Med Assoc; 2008 Dec; 101(12):347-50. PubMed ID: 19177997
    [No Abstract]   [Full Text] [Related]  

  • 26. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attending to anxiety disorders in primary care.
    Stein MB
    J Clin Psychiatry; 2003; 64 Suppl 15():35-9. PubMed ID: 14658989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empirically supported treatments for panic disorder.
    McHugh RK; Smits JA; Otto MW
    Psychiatr Clin North Am; 2009 Sep; 32(3):593-610. PubMed ID: 19716992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
    Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
    J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up.
    Knekt P; Lindfors O; Härkänen T; Välikoski M; Virtala E; Laaksonen MA; Marttunen M; Kaipainen M; Renlund C;
    Psychol Med; 2008 May; 38(5):689-703. PubMed ID: 18005493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of algorithms to treat anxiety in primary care.
    Culpepper L
    J Clin Psychiatry; 2003; 64 Suppl 2():30-3. PubMed ID: 12625797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacotherapy of children with depressive disorders].
    Denizot H; Laporte F; Llorca PM
    Arch Pediatr; 2009 Aug; 16(8):1208-12. PubMed ID: 19586758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Touch and psychotherapy.
    LaTorre MA
    Perspect Psychiatr Care; 2000; 36(3):105-6. PubMed ID: 11111597
    [No Abstract]   [Full Text] [Related]  

  • 35. Anxiety disorders and insomnia in geriatric patients.
    Folks DG; Fuller WC
    Psychiatr Clin North Am; 1997 Mar; 20(1):137-64. PubMed ID: 9139287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute anxiety attack. Diagnostic orientation and management in an emergency situation with drug dosage].
    Llorca PM
    Rev Prat; 2001 Feb; 51(3):309-12. PubMed ID: 11265429
    [No Abstract]   [Full Text] [Related]  

  • 37. Muscle relaxation therapy for anxiety disorders: it works but how?
    Conrad A; Roth WT
    J Anxiety Disord; 2007; 21(3):243-64. PubMed ID: 16949248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nature and duration of treatment for GAD.
    Lader MH
    Acta Psychiatr Scand Suppl; 1998; 393():109-17. PubMed ID: 9777056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome of anxiety disorders: a review of double-blind studies.
    Thuile J; Even C; Rouillon F
    Curr Opin Psychiatry; 2009 Jan; 22(1):84-9. PubMed ID: 19122539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.